… Treatment with desvenlafaxine was generally safe and well … (one evaluating desvenlafaxine
20–35 mg/day and 25–50 mg/… of children and adolescent outpatients with MDD. Both studies …

… treated with a flexible dosage of desvenlafaxine (25, 50, 100 mg/day) for up to 10 months
[Citation78], as well as in adult outpatients from United States and Japan treated with 25 …

… antidepressant with favorable safety and tolerability in adults. … -controlled study in outpatient
children and adolescents over … of desvenlafaxine in this study ranged from 50 to 100 mg/day…

… only included outpatients, whereas our study included both in- and … safety profile of
desvenlafaxine XL in this study was similar to that in prior studies, without new safety or tolerability …

… overall efficacy, superior safety profile, more tolerable side … attending the psychiatry
outpatient department and newly … (10–20 mg/day) and desvenlafaxine (50–100 mg/day) used in …

… mg/day is effective and well tolerated, showing a high remission rate of depressive symptoms
in depressed outpatients. … -controlled trials of desvenlafaxine in major depressive disorder. …

… 3 times stronger than desvenlafaxine. Although ansofaxine is a methyl benzoate …
desvenlafaxine and can be quickly converted to desvenlafaxine in vivo, ansofaxine and …

… Efficacy, safety, and tolerability of desvenlafaxine 50 mg/day and 100 mg/day in outpatients
with major depressive disorder. … Efficacy, safety, and tolerability of fixed-dose desvenlafaxine …

… Non-psychotic, non-bipolar outpatients aged 20–65 having … Tolerability was assessed at
each visit by self-rated scales and … mg/day (sd = 12), with 7 taking 50 mg/day, and 52 taking 100 …

… , which indicated a better profile of sexual tolerability … outpatients with major depression
were randomly assigned 12 weeks of double-blind treatment with desvenlafaxine at 50 mg/day …